Repisaludmetadata only
Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies.
body mass index, docetaxel, early‐stage breast cancer, paclitaxel, pooled analysis, survival, adult, aged
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 462147
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.